vs

Side-by-side financial comparison of CENTRUS ENERGY CORP (LEU) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $146.2M, roughly 1.4× CENTRUS ENERGY CORP). On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs -3.6%). REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $-58.0M). Over the past eight quarters, CENTRUS ENERGY CORP's revenue compounded faster (82.9% CAGR vs 14.4%).

Centrus Energy Corp. is an American company that supplies nuclear fuel for use in nuclear power plants and works to develop and deploy centrifuge technology to produce enriched uranium for commercial and government uses, including for national security.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

LEU vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.4× larger
RGEN
$197.9M
$146.2M
LEU
Growing faster (revenue YoY)
RGEN
RGEN
+17.2% gap
RGEN
13.6%
-3.6%
LEU
More free cash flow
RGEN
RGEN
$75.6M more FCF
RGEN
$17.6M
$-58.0M
LEU
Faster 2-yr revenue CAGR
LEU
LEU
Annualised
LEU
82.9%
14.4%
RGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LEU
LEU
RGEN
RGEN
Revenue
$146.2M
$197.9M
Net Profit
$13.3M
Gross Margin
23.9%
52.5%
Operating Margin
8.8%
9.0%
Net Margin
6.7%
Revenue YoY
-3.6%
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$0.52
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LEU
LEU
RGEN
RGEN
Q4 25
$146.2M
$197.9M
Q3 25
$74.9M
$188.8M
Q2 25
$154.5M
$182.4M
Q1 25
$73.1M
$169.2M
Q4 24
$151.6M
$174.1M
Q3 24
$57.7M
$154.9M
Q2 24
$189.0M
$154.1M
Q1 24
$43.7M
$151.3M
Net Profit
LEU
LEU
RGEN
RGEN
Q4 25
$13.3M
Q3 25
$3.9M
$14.9M
Q2 25
$28.9M
$14.9M
Q1 25
$27.2M
$5.8M
Q4 24
$-30.3M
Q3 24
$-5.0M
$-654.0K
Q2 24
$30.6M
$3.3M
Q1 24
$-6.1M
$2.1M
Gross Margin
LEU
LEU
RGEN
RGEN
Q4 25
23.9%
52.5%
Q3 25
-5.7%
53.2%
Q2 25
34.9%
50.0%
Q1 25
45.0%
53.6%
Q4 24
40.8%
26.1%
Q3 24
15.4%
50.0%
Q2 24
19.3%
49.8%
Q1 24
9.8%
49.5%
Operating Margin
LEU
LEU
RGEN
RGEN
Q4 25
8.8%
9.0%
Q3 25
-22.2%
8.9%
Q2 25
21.7%
7.6%
Q1 25
28.0%
3.9%
Q4 24
29.7%
-17.7%
Q3 24
-13.2%
-5.1%
Q2 24
11.2%
1.0%
Q1 24
-24.3%
1.3%
Net Margin
LEU
LEU
RGEN
RGEN
Q4 25
6.7%
Q3 25
5.2%
7.9%
Q2 25
18.7%
8.2%
Q1 25
37.2%
3.4%
Q4 24
-17.4%
Q3 24
-8.7%
-0.4%
Q2 24
16.2%
2.2%
Q1 24
-14.0%
1.4%
EPS (diluted)
LEU
LEU
RGEN
RGEN
Q4 25
$0.52
$0.24
Q3 25
$0.19
$0.26
Q2 25
$1.59
$0.26
Q1 25
$1.60
$0.10
Q4 24
$3.26
$-0.55
Q3 24
$-0.30
$-0.01
Q2 24
$1.89
$0.06
Q1 24
$-0.38
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LEU
LEU
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$2.0B
$767.6M
Total DebtLower is stronger
$1.2B
$542.2M
Stockholders' EquityBook value
$765.1M
$2.1B
Total Assets
$2.4B
$2.9B
Debt / EquityLower = less leverage
1.54×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LEU
LEU
RGEN
RGEN
Q4 25
$2.0B
$767.6M
Q3 25
$1.6B
$748.7M
Q2 25
$833.0M
$708.9M
Q1 25
$653.0M
$697.2M
Q4 24
$671.4M
$757.4M
Q3 24
$194.3M
$784.0M
Q2 24
$227.0M
$809.1M
Q1 24
$209.3M
$780.6M
Total Debt
LEU
LEU
RGEN
RGEN
Q4 25
$1.2B
$542.2M
Q3 25
$1.2B
$537.9M
Q2 25
$390.0M
Q1 25
$389.5M
Q4 24
$472.5M
$525.6M
Q3 24
$83.5M
Q2 24
$86.5M
Q1 24
$86.5M
Stockholders' Equity
LEU
LEU
RGEN
RGEN
Q4 25
$765.1M
$2.1B
Q3 25
$363.1M
$2.1B
Q2 25
$359.1M
$2.1B
Q1 25
$213.9M
$2.0B
Q4 24
$161.4M
$2.0B
Q3 24
$76.4M
$2.0B
Q2 24
$76.6M
$2.0B
Q1 24
$33.8M
$2.0B
Total Assets
LEU
LEU
RGEN
RGEN
Q4 25
$2.4B
$2.9B
Q3 25
$2.2B
$2.9B
Q2 25
$1.3B
$2.9B
Q1 25
$1.3B
$2.9B
Q4 24
$1.1B
$2.8B
Q3 24
$591.0M
$2.8B
Q2 24
$668.2M
$2.9B
Q1 24
$750.0M
$2.8B
Debt / Equity
LEU
LEU
RGEN
RGEN
Q4 25
1.54×
0.26×
Q3 25
3.23×
0.26×
Q2 25
1.09×
Q1 25
1.82×
Q4 24
2.93×
0.27×
Q3 24
1.09×
Q2 24
1.13×
Q1 24
2.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LEU
LEU
RGEN
RGEN
Operating Cash FlowLast quarter
$-48.4M
$25.7M
Free Cash FlowOCF − Capex
$-58.0M
$17.6M
FCF MarginFCF / Revenue
-39.7%
8.9%
Capex IntensityCapex / Revenue
6.6%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$31.3M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LEU
LEU
RGEN
RGEN
Q4 25
$-48.4M
$25.7M
Q3 25
$10.1M
$48.1M
Q2 25
$52.8M
$28.6M
Q1 25
$36.5M
$15.0M
Q4 24
$57.9M
$39.2M
Q3 24
$-33.2M
$49.3M
Q2 24
$7.0M
$42.2M
Q1 24
$5.3M
$44.7M
Free Cash Flow
LEU
LEU
RGEN
RGEN
Q4 25
$-58.0M
$17.6M
Q3 25
$5.7M
$43.4M
Q2 25
$49.2M
$21.5M
Q1 25
$34.4M
$11.4M
Q4 24
$57.2M
$33.6M
Q3 24
$-34.2M
$42.3M
Q2 24
$6.1M
$37.4M
Q1 24
$3.8M
$36.4M
FCF Margin
LEU
LEU
RGEN
RGEN
Q4 25
-39.7%
8.9%
Q3 25
7.6%
23.0%
Q2 25
31.8%
11.8%
Q1 25
47.1%
6.8%
Q4 24
37.7%
19.3%
Q3 24
-59.3%
27.3%
Q2 24
3.2%
24.3%
Q1 24
8.7%
24.0%
Capex Intensity
LEU
LEU
RGEN
RGEN
Q4 25
6.6%
4.1%
Q3 25
5.9%
2.5%
Q2 25
2.3%
3.9%
Q1 25
2.9%
2.1%
Q4 24
0.5%
3.2%
Q3 24
1.7%
4.5%
Q2 24
0.5%
3.1%
Q1 24
3.4%
5.5%
Cash Conversion
LEU
LEU
RGEN
RGEN
Q4 25
1.93×
Q3 25
2.59×
3.23×
Q2 25
1.83×
1.92×
Q1 25
1.34×
2.57×
Q4 24
Q3 24
Q2 24
0.23×
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LEU
LEU

Separative Work Units$111.0M76%
Services$21.8M15%
Other$13.4M9%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons